Soliton, Inc., a medical device company with a proprietary aesthetic platform technology, has announced the appointment of Brad A. Hauser as President and Chief Executive Officer of Soliton. He most recently served as vice president, R&D and general manager for CoolSculpting at Allergan Aesthetics, an AbbVie Company, since Allergan's April 2017 acquisition of Zeltiq Aesthetics, Inc.
Read more at PR Newswire >>